US expert panel recommends authorising J&J Covid vaccine

An independent panel of US experts voted unanimously in favor of granting emergency approval to Johnson & Johnson's one-shot Covid-19 vaccine, clearing the way for a third vaccine to be authorised in the world's hardest hit country.

Read more: Pfizer Covid-19 vaccine reduces transmission after one dose: UK study

"I think what we have to keep in mind is that we're still in the midst of this deadly pandemic, there is a shortage of vaccines that are currently authorized," said Archana Chatterjee, a panelist, explaining her vote.

"I think authorisation of this vaccine will help meet the needs at the moment."